Lymphovascular Invasion Is Associated With Doxorubicin Resistance in Breast Cancer

被引:0
|
作者
Corachea, Allen Joy M. [1 ]
Ferrer, Regina Joyce E. [1 ]
Ty, Lance Patrick B. [1 ]
Aquino, Lizzie Anne C. [2 ]
Morta, Madeleine T. [1 ]
Macalindong, Shiela S. [2 ]
Uy, Gemma Leonora B. [2 ]
Odono, Eugene G. [3 ]
Llames, Jo-Hannah S. [4 ]
Tablizo, Francis A. [4 ]
Paz, Eva Maria C. Cutiongco-Dela [5 ]
Dofitas, Rodney B. [2 ]
Velarde, Michael C. [1 ]
机构
[1] Univ Philippines Diliman, Inst Biol, Coll Sci, Quezon City, Philippines
[2] Univ Philippines Manila, Philippine Gen Hosp, Dept Surg, Manila, Philippines
[3] Univ Philippines Manila, Philippine Gen Hosp, Dept Pathol, Manila, Philippines
[4] Univ Philippines, Philippine Genome Ctr, Quezon City, Philippines
[5] Univ Philippines Manila, NIH, Manila, Philippines
关键词
breast cancer; lymphovascular invasion; drug resistance; patient-derived organoids; SURGICAL ADJUVANT BREAST; NEOADJUVANT TREATMENT; ENRICHMENT ANALYSIS; CYP1B1; INHIBITORS; DOCETAXEL; DISEASE; MODELS;
D O I
10.1016/j.labinv.2025.104115
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Lymphovascular invasion (LVI), the invasion of tumor cells into the lymphatic or vascular space, is an early indicator of potential metastasis, with its presence in breast cancer independently predicting poorer outcomes even after neoadjuvant chemotherapy. However, a major limitation is that LVI detection currently relies on postsurgical evaluation. To address this, we determined whether LVI+ breast tumors contain a unique gene signature that could facilitate earlier detection. Here, we conducted an integrative analysis of the gene profile between LVI+ and LVI- primary breast tumors from various sources, including published data and our own research, using both microarray and RNA-seq data. Our analysis revealed protein binding and vesicle-related genes to be the most enriched categories in LVI+ vs LVI- tumors. Furthermore, LVI+ tumors showed enrichment for xenobiotic metabolism genes, particularly drug metabolism enzymes, such as cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases. An elastic net regression model containing 13 of these uridine 5'-diphospho-glucuronosyltransferases and cytochrome P450 genes can predict LVI status with 92% accuracy. This suggests a potential link to drug resistance, which was further confirmed by the finding that patients with LVI+ tumors had a significantly lower clinical response rate than individuals with LVI- tumors. We also observed this resistance in patient-derived organoids, with LVI+ organoids exhibiting lower sensitivity to doxorubicin, implying that doxorubicin might be less effective for LVI+ breast cancer, potentially contributing to poorer outcomes. Overall, our study unlocked an exciting opportunity for personalized medicine, in that, therapy efficacy and patient outcomes can be improved by incorporating the LVI-associated gene signature into treatment plans. (c) 2025 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Effect of Lymphangiogenesis and Lymphovascular Invasion on the Survival Pattern of Breast Cancer Patients
    Sahoo, Pradyumna Kumar
    Jana, Debarshi
    Mandal, Palash Kumar
    Basak, Samindranath
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (15) : 6287 - 6293
  • [42] Relationship between lymphovascular invasion and molecular subtypes in invasive breast cancer
    Morkavuk, Sevket Baris
    Guner, Murat
    Culcu, Serdar
    Eroglu, Aydan
    Bayar, Sancar
    Unal, Ali Ekrem
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [43] The role of multiparametric MRI in predicting lymphovascular invasion in breast cancer patients
    Wang, Jinhua
    Jing, Siqing
    Yang, Zhongxian
    Tan, Wanchang
    Liu, Yubao
    FUTURE ONCOLOGY, 2024, 20 (35) : 2747 - 2756
  • [44] Lymphovascular invasion in breast cancer: improved methods of detection and clinical significance
    RAA Mohammed
    SG Martin
    MS Gill
    AR Green
    EC Paish
    IO Ellis
    Breast Cancer Research, 10
  • [45] LYMPHOVASCULAR INVASION AND PERINEURAL INVASION ARE ASSOCIATED WITH ADVANCED DISEASE AND POOR SURVIVAL IN COLORECTAL CANCER
    Al-Sukhni, E.
    Attwood, K.
    Gabriel, E.
    Nurkin, S.
    DISEASES OF THE COLON & RECTUM, 2015, 58 (05) : E312 - E312
  • [46] The Presence of Extensive Lymphovascular Invasion (LVI) is Associated with Higher Risk of Recurrence in Curatively Treated Breast Cancer Patients
    Koleoso, O. A.
    Toumbacaris, N.
    Zhang, Z.
    Braunstein, L. Z.
    El -Tamer, M.
    Moo, T. A.
    Morrow, M.
    Brogi, E.
    Xu, A. J.
    Powell, S. N.
    Khan, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S135 - S136
  • [47] Expression of cyclooxygenase-2 in cervical cancer is associated with lymphovascular invasion
    Hoellen, Friederike
    Waldmann, Annika
    Banz-Jansen, Constanze
    Rody, Achim
    Heide, Maria
    Koester, Frank
    Ribbat-Idel, Julika
    Thorns, Christoph
    Gebhard, Maximilian
    Oberlaender, Martina
    Habermann, Jens K.
    Thill, Marc
    ONCOLOGY LETTERS, 2016, 12 (04) : 2351 - 2356
  • [48] Risk of nodal metastasis associated with lymphovascular space invasion in endometrial cancer
    Tatar, Burak
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (05) : 850 - 854
  • [49] Prognostic significance of Cell Division Cycle Associated 5 (CDCA5): A biomarker Associated with Lymphovascular Invasion in Breast Cancer
    Kariri, Yousif Ahmad
    Joseph, Chitra
    Alsaleem, Mansour
    Aljohani, Abrar
    Alsaeed, Sami
    Narasimha, Pavan Lakshmi
    Mongan, Nigel P.
    Ellis, Ian O.
    Aleskandarany, Mohammed
    Green, Andrew R.
    Rakha, Emad A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 547 - 547
  • [50] Prognostic Significance of Isocitrate Dehydrogenase 2 (IDH2): A Biomarker Associated with Lymphovascular Invasion in Breast Cancer
    Aljohani, A.
    Kurozumi, S.
    Joseph, C.
    Aleskandarany, M. A.
    Alsaeed, S.
    Kariri, Y.
    Narasimha, P. L.
    Ellis, I.
    Green, A.
    Rakha, E.
    JOURNAL OF PATHOLOGY, 2019, 249 : S16 - S16